Simon was appointed to the Board of Directors in December 2022.
He is an experienced senior global pharma executive with 30 years’ of experience in the biotechnology industry focused on the discovery, development and commercialisation of life saving medicines.
He was actively involved in CSL’s global expansion over a 17-year period and held roles as Senior Vice President, Global Plasma R&D and General Manager of CSL’s manufacturing plants in Germany and Australia.
Prior to joining CSL he worked in the USA at leading biotechnology companies Genentech Inc and Chiron Corporation.
His skills cover R&D drug development, corporate due diligence, mergers and acquisitions, strategic planning, portfolio management, financial management, intellectual property management, business development, contract management and organisational design.
Simon was educated at Monash University (Bachelor’s Degree in Science with Honours) and the University of Melbourne (Doctor of Philosophy, Biochemistry and Immunology). He is also a graduate of the Australian Institute of Company Directors’ company directors course.
He is a non-executive director of Clover Corporation Limited and is the founder and CEO of Immunosis Pty Ltd, a start-up diagnostics company.